Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 665

DECLARATION re #664 Reply to Response to Motion for Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 by Amgen Inc.. (Rich, Patricia) Additional attachment(s) added on 8/1/2007 (Paine, Matthew).

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 665

Case 1:05-cv-12237-WGY

Document 665

Filed 07/09/2007

Page 1 of 4

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

AMGEN INC.,

) ) Plaintiff, ) ) Civil Action No.: 05-12237 WGY v. ) ) ) F. HOFFMANN-LA ROCHE ) LTD., a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN-LA ROCHE ) INC., a New Jersey Corporation, ) ) Defendants. ) __________________________________________)

DECLARATION OF ROBERT M. GALVIN IN SUPPORT OF AMGEN INC.'S REPLY IN SUPPORT OF ITS MOTION FOR SUMMARY JUDGMENT OF INFRINGEMENT OF `422 CLAIM 1, `933 CLAIM 3, AND `698 CLAIM 6

Contains Amgen/Roche Highly Confidential and Roche Restricted Access Confidential BLA/IND Information Subject to Protective Order

730389_1.doc

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 665

Filed 07/09/2007

Page 2 of 4

I, Robert M. Galvin, declare that: 1. I am an attorney admitted to practice law before all the Courts of the State of

California and before this Court (pro hac vice). I am member of Day Casebeer Madrid & Batchelder LLP, counsel for Plaintiff, Amgen, Inc. in this matter. 2. I make this declaration of my own personal knowledge. If called to testify as to

the truth of the matters stated herein, I could and would do so competently. 3. Attached hereto as Exhibit 1 is a true and correct copy of a document titled

"Elucidation of Structure ­ Summary: Evidence of Structure" , bearing production numbers ITCR-BLA-00004232 to ITC-R-BLA-00004239, designated by Roche as Restricted Access BLA/IND Confidential Information. 4. Attached hereto as Exhibit 2 is a true and correct copy of excerpts of the

Deposition Transcript of Carolyn Bertozzi, Ph.D., dated June 26, 2007, transcript pages 380-381, designated by Roche as Restricted Access BLA/IND Confidential Information. 5. Attached hereto as Exhibit 3 is a true and correct copy of excerpts of the

Deposition Transcript of Edward E. Harlow, Jr., Ph.D., dated June 20, 2007, transcript pages 6566, designated by Roche as Confidential. 6. Attached hereto as Exhibit 4 is a true and correct copy of excerpts of the

Deposition Transcript of Michael Mayersohn, Ph.D., dated June 15, 2007, transcript pages 175176, designated by Roche as Confidential. 7. Attached hereto as Exhibit 5 is a true and correct copy of excerpts of the

Deposition Transcript of Dr. Alexander Klibanov, dated May 23, 2007, transcript pages 83-90, designated by Roche as Highly Confidential and as containing Restricted Access BLA/IND Confidential Information.

1

Case 1:05-cv-12237-WGY

Document 665

Filed 07/09/2007

Page 3 of 4

I declare under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

Signed this 9th day of July, 2007

/s/ Robert M. Galvin Robert M. Galvin

2

Case 1:05-cv-12237-WGY

Document 665

Filed 07/09/2007

Page 4 of 4

CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of electronic filing and paper copies will be sent to those indicated as non-registered participants. /s/ Michael R. Gottfried Michael R. Gottfried